Since MDR1 protects against xenotoxins primarily through its efflux function, the results of this study suggest a unique mitochondrial toxin genetic susceptibility interaction leading to mitochondrial dysfunction, a novel pathogenic mechanism that could provide many new therapeutic opportunities for IBD (Ho et al., 2018). The gene discussed is ABCB1; the disease is inflammatory bowel disease.